{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T08:42:45Z","timestamp":1761986565999,"version":"3.37.3"},"reference-count":29,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T00:00:00Z","timestamp":1672876800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,6,19]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n               <jats:p>Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), presents with severe pneumonia and fatal systemic complications. Currently, SARS-CoV-2 vaccines are effective in reducing the risk of new onset and getting worse of the disease. However, autoimmune diseases such as antineutrophil cytoplasmic antibody (ANCA)\u2013associated vasculitis (AAV) have been reported to develop after COVID-19 vaccine administration. A 71-year-old woman presented with fever, malaise, urinary abnormalities, and renal dysfunction after receiving the COVID-19 vaccine (Pfizer-BioNTech). We clinically diagnosed AAV with her manifestations and serological test (myeloperoxidase-ANCA-positive). Her clinical findings were improved after immunosuppressive therapy. We examined her genetic susceptibility to AAV, and we found that her allele was HLA-DRB1*09:01, which is a risk allele of myeloperoxidase-AAV. Mechanistically, SARS-CoV-2 vaccines would activate immunity, including neutrophils, and trigger AAV onset in this patient with a genetic risk to develop AAV. The pathophysiology of this case would share with that of autoimmune\/inflammatory syndrome induced by adjuvants in the absence of external adjuvants.<\/jats:p>","DOI":"10.1093\/mrcr\/rxac093","type":"journal-article","created":{"date-parts":[[2023,1,8]],"date-time":"2023-01-08T01:30:51Z","timestamp":1673141451000},"page":"426-430","source":"Crossref","is-referenced-by-count":9,"title":["Development of ANCA-associated vasculitis followed by SARS-CoV-2 vaccination in a patient with HLA-DRB1*09:01 allele"],"prefix":"10.1093","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4346-8378","authenticated-orcid":false,"given":"Takuro","family":"Kawamura","sequence":"first","affiliation":[{"name":"Department of Rheumatology and Nephrology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University , Sapporo, Hokkaid\u00f4, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daigo","family":"Nakazawa","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Nephrology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University , Sapporo, Hokkaid\u00f4, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saori","family":"Nishio","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Nephrology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University , Sapporo, Hokkaid\u00f4, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taiki","family":"Isozaki","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Nephrology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University , Sapporo, Hokkaid\u00f4, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maki","family":"Komatsumoto","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Nephrology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University , Sapporo, Hokkaid\u00f4, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuya","family":"Atsumi","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Nephrology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University , Sapporo, Hokkaid\u00f4, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2023,1,5]]},"reference":[{"key":"2023061920013451900_R1","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine","volume":"383","author":"Polack","year":"2020","journal-title":"N Engl J Med"},{"key":"2023061920013451900_R2","first-page":"1663","article-title":"COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer\/BioNTech and Moderna Vaccines","volume":"25","author":"Meo","year":"2021","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"2023061920013451900_R3","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1093\/ndt\/gfab215","article-title":"Nephrotic syndrome and vasculitis following SARS-CoV-2 vaccine: true association or circumstantial?","volume":"36","author":"Izzedine","year":"2021","journal-title":"Nephrol Dial Transplant"},{"key":"2023061920013451900_R4","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1007\/s13730-021-00646-2","article-title":"A case of anti-GBM nephritis following centipede bites and COVID-19 vaccination","volume":"11","author":"Nagai","year":"2022","journal-title":"CEN Case Rep"},{"key":"2023061920013451900_R5","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.kint.2021.05.016","article-title":"De novo vasculitis after mRNA-1273 (Moderna) vaccination","volume":"100","author":"Anderegg","year":"2021","journal-title":"Kidney Int"},{"key":"2023061920013451900_R6","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1053\/j.ajkd.2021.06.016","article-title":"ANCA-Associated Vasculitis Following Pfizer-BioNTech COVID-19 Vaccine","volume":"78","author":"Shakoor","year":"2021","journal-title":"Am J Kidney Dis"},{"key":"2023061920013451900_R7","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.762006","article-title":"Case report: ANCA-associated vasculitis presenting with rhabdomyolysis and pauci-immune crescentic glomerulonephritis after Pfizer-BioNTech COVID-19 mRNA vaccination","volume":"12","author":"Hakroush","year":"2021","journal-title":"Front Immunol"},{"key":"2023061920013451900_R8","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1093\/ckj\/sfab181","article-title":"MPO-ANCA-associated vasculitis after the Pfizer\/BioNTech SARS-CoV-2 vaccination","volume":"15","author":"Obata","year":"2022","journal-title":"Clin Kidney J"},{"key":"2023061920013451900_R9","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.kint.2021.05.017","article-title":"ANCA glomerulonephritis after the Moderna COVID-19 vaccination","volume":"100","author":"Sekar","year":"2021","journal-title":"Kidney Int"},{"key":"2023061920013451900_R10","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.kint.2021.07.026","article-title":"A case of ANCA-associated vasculitis after AZD1222 (Oxford-AstraZeneca) SARS-CoV-2 vaccination: casualty or causality?","volume":"100","author":"Villa","year":"2021","journal-title":"Kidney Int"},{"key":"2023061920013451900_R11","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1007\/s10067-015-3073-0","article-title":"Viral RNA in the influenza vaccine may have contributed to the development of ANCA-associated vasculitis in a patient following immunisation","volume":"35","author":"Jeffs","year":"2016","journal-title":"Clin Rheumatol"},{"key":"2023061920013451900_R12","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1159\/000354084","article-title":"Antineutrophil cytoplasmic antibody vasculitis associated with influenza vaccination","volume":"38","author":"Duggal","year":"2013","journal-title":"Am J Nephrol"},{"key":"2023061920013451900_R13","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/RHU.0b013e3181b55fe4","article-title":"ANCA-associated vasculitis following influenza vaccination: causal association or mere coincidence?","volume":"15","author":"Birck","year":"2009","journal-title":"J Clin Rheumatol"},{"key":"2023061920013451900_R14","first-page":"414","article-title":"Minimal change disease following influenza vaccination and acute renal failure: just a coincidence?","volume":"32","author":"Guti\u00e9rrez","year":"2012","journal-title":"Nefrologia"},{"key":"2023061920013451900_R15","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.jaut.2010.07.003","article-title":"\u2018ASIA\u2019 \u2013 autoimmune\/inflammatory syndrome induced by adjuvants","volume":"36","author":"Shoenfeld","year":"2011","journal-title":"J Autoimmun"},{"key":"2023061920013451900_R16","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1053\/j.ajkd.2004.03.030","article-title":"Treatment with the purine synthesis inhibitor mizoribine for ANCA-associated renal vasculitis","volume":"44","author":"Hirayama","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"2023061920013451900_R17","doi-asserted-by":"crossref","DOI":"10.1093\/ndt\/gfac067.017","article-title":"MO218: ANCA-associated vasculitis after SARS-COV-2 vaccination in a patient with HLA-DRB1*09:01 ALLELE: a case report and literature review","volume":"37","author":"Kawamura","year":"2022","journal-title":"Nephrol Dial Transplant"},{"key":"2023061920013451900_R18","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/s41584-018-0145-y","article-title":"Pathogenesis and therapeutic interventions for ANCA-associated vasculitis","volume":"15","author":"Nakazawa","year":"2019","journal-title":"Nat Rev Rheumatol"},{"key":"2023061920013451900_R19","article-title":"Advances in mRNA Vaccines for Infectious Diseases","volume":"10","author":"Zhang","year":"2019","journal-title":"Front Immunol"},{"key":"2023061920013451900_R20","first-page":"69","article-title":"Extracellular RNAs from lung cancer cells activate epithelial cells and induce neutrophil extracellular traps","volume":"55","author":"Li","year":"2019","journal-title":"Int J Oncol"},{"key":"2023061920013451900_R21","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1177\/0961203309345724","article-title":"Adjuvants and autoimmunity","volume":"18","author":"Israeli","year":"2009","journal-title":"Lupus"},{"key":"2023061920013451900_R22","doi-asserted-by":"crossref","first-page":"64","DOI":"10.31138\/mjr.28.2.64","article-title":"The ASIA syndrome: basic concepts","volume":"28","author":"Watad","year":"2017","journal-title":"Mediterr J Rheumatol"},{"key":"2023061920013451900_R23","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1002\/art.10465","article-title":"HLA-DRB1*01 and macrophagic myofasciitis","volume":"46","author":"Guis","year":"2002","journal-title":"Arthritis Rheum"},{"key":"2023061920013451900_R24","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1097\/00006534-199512000-00001","article-title":"HLA typing in women with breast implants","volume":"96","author":"Young","year":"1995","journal-title":"Plast Reconstr Surg"},{"key":"2023061920013451900_R25","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1007\/s10157-012-0691-6","article-title":"Genetics of ANCA-associated vasculitis in Japan: a role for HLA-DRB1*09:01 haplotype","volume":"17","author":"Tsuchiya","year":"2013","journal-title":"Clin Exp Nephrol"},{"key":"2023061920013451900_R26","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0099453","article-title":"Protective effect of the HLA-DRB1*13:02 allele in Japanese rheumatoid arthritis patients","volume":"9","author":"Oka","year":"2014","journal-title":"PLoS One"},{"key":"2023061920013451900_R27","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1093\/rheumatology\/kes427","article-title":"An association analysis of HLA-DRB1 with systemic lupus erythematosus and rheumatoid arthritis in a Japanese population: effects of *09:01 allele on disease phenotypes","volume":"52","author":"Shimane","year":"2013","journal-title":"Rheumatology (Oxford)"},{"key":"2023061920013451900_R28","doi-asserted-by":"crossref","first-page":"545","DOI":"10.2337\/diabetes.51.2.545","article-title":"Asian-specific HLA haplotypes reveal heterogeneity of the contribution of HLA-DR and -DQ haplotypes to susceptibility to type 1 diabetes","volume":"51","author":"Kawabata","year":"2002","journal-title":"Diabetes"},{"key":"2023061920013451900_R29","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1080\/24725625.2020.1738983","article-title":"Contribution of HLA-DRB1 * 09: 01 allele to development of minocycline induced antineutrophil cytoplasmic antibody (ANCA)-associated cutaneous vasculitis: report of two cases","volume":"4","author":"Kawahara","year":"2020","journal-title":"Mod Rheumatol Case Rep"}],"container-title":["Modern Rheumatology Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/mrcr\/advance-article-pdf\/doi\/10.1093\/mrcr\/rxac093\/48533022\/rxac093.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/mrcr\/article-pdf\/7\/2\/426\/50646456\/rxac093.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/mrcr\/article-pdf\/7\/2\/426\/50646456\/rxac093.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,19]],"date-time":"2023-06-19T20:06:48Z","timestamp":1687205208000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/mrcr\/article\/7\/2\/426\/6970048"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,5]]},"references-count":29,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2023,1,5]]},"published-print":{"date-parts":[[2023,6,19]]}},"URL":"https:\/\/doi.org\/10.1093\/mrcr\/rxac093","relation":{},"ISSN":["2472-5625"],"issn-type":[{"type":"electronic","value":"2472-5625"}],"subject":[],"published-other":{"date-parts":[[2023,7,1]]},"published":{"date-parts":[[2023,1,5]]}}}